METASTATIC SOLID TUMORS
Clinical trials for METASTATIC SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new METASTATIC SOLID TUMORS trials appear
Sign up with your email to follow new studies for METASTATIC SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy cocktail shows promise against tough cancers
Disease control CompletedThis study tested a new immunotherapy drug called ezabenlimab (BI 754091) combined with other cancer medicines in 211 adults with advanced solid tumors that had spread. The goal was to see if the combinations could shrink or eliminate tumors. Participants received treatment until…
Matched conditions: METASTATIC SOLID TUMORS
Phase: PHASE2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
Cancer drug safety checked in Long-Term study
Disease control CompletedThis study checked the long-term safety of the drug sacituzumab govitecan in 25 people with metastatic solid tumors (cancer that has spread) who were already benefiting from the treatment. Researchers tracked side effects and lab abnormalities. The goal was to see how safe the dr…
Matched conditions: METASTATIC SOLID TUMORS
Phase: PHASE4 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
Experimental triple therapy shows promise for stubborn tumors
Disease control CompletedThis early-phase study tested a combination of three drugs—interleukin-15 (IL-15), nivolumab, and ipilimumab—in 31 adults with cancers that no longer respond to standard treatments. The goal was to find the safest dose and see if the drugs could help the immune system attack tumo…
Matched conditions: METASTATIC SOLID TUMORS
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 12, 2026 13:40 UTC
-
New cancer drug combo tested in early trial – no cure yet
Disease control CompletedThis early-phase study tested a new drug called M6223, alone or with another drug (bintrafusp alfa), in 58 people with advanced solid tumors that had stopped responding to standard treatments. The main goal was to check safety and find the best dose. The study is complete, but re…
Matched conditions: METASTATIC SOLID TUMORS
Phase: PHASE1 • Sponsor: EMD Serono Research & Development Institute, Inc. • Aim: Disease control
Last updated May 11, 2026 20:49 UTC
-
Massive study reveals rare genetic markers in Hard-to-Treat cancers
Knowledge-focused CompletedThis completed study looked at nearly 4,000 people with advanced solid tumors to find how many had a specific genetic change called an NTRK fusion. Researchers used advanced DNA and RNA testing on tumor samples to count these fusions. The goal was to understand how common these g…
Matched conditions: METASTATIC SOLID TUMORS
Sponsor: Institut Bergonié • Aim: Knowledge-focused
Last updated May 17, 2026 02:03 UTC
-
Study reveals key factors predicting survival in advanced cancer patients after ER visit
Knowledge-focused CompletedThis study looked at 1,250 adults with advanced cancer who visited the emergency room to find out what factors are linked to dying within 90 days. Researchers checked medical records and lab results to create risk profiles. The goal is to help doctors identify patients who need e…
Matched conditions: METASTATIC SOLID TUMORS
Sponsor: Ankara Etlik City Hospital • Aim: Knowledge-focused
Last updated May 14, 2026 12:02 UTC